BiomX Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Bassan Merav | Chief Development Officer | Award / Grant | 79,597 | — | — | 79,597 | Apr 14, 2025 |
| Solomon Jonathan Eitan | Chief Executive Officer | Award / Grant | 126,748 | — | — | 126,748 | Apr 14, 2025 |
| Wolfson Marina | Chief Financial Officer | Award / Grant | 68,545 | — | — | 68,545 | Apr 14, 2025 |
| Wolfson Marina | Chief Financial Officer | Award / Grant | 68,545 | — | — | 68,545 | Apr 14, 2025 |
| Bassan Merav | Chief Development Officer | Award / Grant | 79,597 | — | — | 79,597 | Apr 14, 2025 |
| Solomon Jonathan Eitan | Chief Executive Officer | Award / Grant | 126,748 | — | — | 126,748 | Apr 14, 2025 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | — | Option Exercise | 353,249 | $0.93 | $328,522 | 1,247,054 | Feb 27, 2025 |
| Bassan Merav | Chief Development Officer | Award / Grant | 31,749 | — | — | 31,749 | Sep 16, 2024 |
| Solomon Jonathan Eitan | Chief Executive Officer | Award / Grant | 50,556 | — | — | 53,056 | Sep 16, 2024 |
| Oron Assaf | Chief Business Officer | Award / Grant | 25,804 | — | — | 25,804 | Sep 16, 2024 |
| Cystic Fibrosis Foundation | — | C | 854,700 | — | — | 1,787,758 | Jul 15, 2024 |
| Deerfield Mgmt HIF, L.P. | — | Option Exercise | 5,883,000 | — | — | 8,938,049 | Jul 15, 2024 |
| GORDON CARL L | — | X | 9,280,408 | $0.24 | $2,227,298 | 13,797,997 | May 15, 2024 |
| Cystic Fibrosis Foundation | — | X | 4,778,265 | — | — | 9,330,580 | May 15, 2024 |
| Deerfield Mgmt HIF, L.P. | — | Award / Grant | 3,055,049 | — | — | 3,055,049 | Mar 15, 2024 |
| Oron Assaf | Chief Business Officer | Sale | 2,056 | $0.34 | $699 | — | Nov 29, 2023 |
| Oron Assaf | Chief Business Officer | Purchase | 3,192 | $0.27 | $862 | 10,914 | May 22, 2023 |
| Oron Assaf | Chief Business Officer | Purchase | 1,201 | $0.27 | $324 | 1,201 | May 19, 2023 |
| OrbiMed Israel GP Ltd. | — | Purchase | 348,000 | $0.25 | $87,000 | 3,161,489 | Feb 27, 2023 |
| Ugwumba Chidozie | — | Sale | 3,072 | $0.37 | $1,137 | 3,023,073 | Oct 26, 2022 |
| Ugwumba Chidozie | — | Sale | 4,866 | $0.33 | $1,606 | 3,270,869 | Sep 23, 2022 |
| Ugwumba Chidozie | — | Sale | 8,563 | $0.73 | $6,251 | 3,583,084 | Aug 17, 2022 |
| Walton Thomas Layton | — | Other | 3,637,846 | — | — | — | Dec 31, 2021 |
| OrbiMed Israel BioFund GP Limited Partnership | — | Purchase | 500,000 | — | — | 2,813,489 | Jul 28, 2021 |
| Wolfson Marina | SVP of Finance & Operations | Purchase | 3,750 | $4.00 | $15,000 | 3,750 | Jul 28, 2021 |
| Sullivan Lynne Marie | — | Purchase | 12,500 | $4.00 | $50,000 | 12,500 | Jul 28, 2021 |
| Solomon Jonathan Eitan | Chief Executive Officer | Purchase | 25,000 | $4.00 | $100,000 | 25,000 | Jul 28, 2021 |
| Greig Russell | — | Purchase | 3,750 | $4.00 | $15,000 | 3,750 | Jul 28, 2021 |
| SEKHRI PAUL J | — | Purchase | 12,500 | $4.00 | $50,000 | 12,500 | Jul 28, 2021 |
| Moses Alan Charles | — | Purchase | 5,000 | $4.00 | $20,000 | 5,000 | Jul 28, 2021 |
| GROSSMAN JONAS | — | Purchase | 37,500 | — | — | 372,717 | Jul 26, 2021 |
| GROSSMAN JONAS | — | Purchase | 37,500 | — | — | 372,217 | Jul 26, 2021 |
| Amusa Gbolahan | — | Purchase | 25,000 | — | — | 262,871 | Jul 26, 2021 |
| Amusa Gbolahan | — | Other | 95,148 | — | — | 237,871 | Jul 13, 2020 |
| Mountain Wood LLC | — | Other | 217,652 | — | — | 260,771 | Jul 13, 2020 |
| GROSSMAN JONAS | — | Other | 229,545 | — | — | 335,217 | Jun 18, 2020 |
| Mountain Wood LLC | — | Other | 999,058 | — | — | 999,058 | Jun 10, 2020 |
| GROSSMAN JONAS | — | Other | 99,172 | — | — | 105,672 | Jun 10, 2020 |
| Amusa Gbolahan | — | Other | 142,723 | — | — | 142,723 | Jun 10, 2020 |
| Chimovits Erez | — | Purchase | 500 | $8.93 | $4,465 | 2,309,989 | Dec 19, 2019 |
| OrbiMed Israel GP Ltd. | — | Purchase | 500 | $8.93 | $4,465 | 2,309,989 | Dec 19, 2019 |
| OrbiMed Israel BioFund GP Limited Partnership | — | Purchase | 3,400 | $8.75 | $29,750 | 2,304,089 | Dec 11, 2019 |
| Chimovits Erez | — | Purchase | 5,400 | $8.92 | $48,168 | 2,309,489 | Dec 10, 2019 |
| Chimovits Erez | — | Purchase | 3,400 | $7.99 | $27,166 | 2,293,889 | Dec 9, 2019 |
| OrbiMed Israel GP Ltd. | — | Purchase | 3,400 | $7.99 | $27,166 | 2,293,889 | Dec 9, 2019 |
| GROSSMAN JONAS | — | Purchase | 4,100 | $7.57 | $31,037 | 5,100 | Nov 20, 2019 |